Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

340

Case Report: ROSAH syndrome presents diagnostic and therapeutic challenges.

Jenny Shunyakova1, Margaret Reynolds2, Amal Taylor2

  • 1Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, Aurora, CO, United States.

Frontiers in Ophthalmology
|April 9, 2025
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retinopathy caused by a primary immune regulatory disorder - the spectrum of AIRE-associated retinopathy: case series and literature review.

Eye (London, England)·2026
Same author

Genomic network analysis links uveitis with systemic inflammatory diseases.

medRxiv : the preprint server for health sciences·2026
Same author

Provider and caregiver perspectives on vision services for childhood cancer survivors: a qualitative study.

BMC health services research·2026
Same author

Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting.

International ophthalmology·2026
Same author

Macrophage immunosenescence prolongs intraocular inflammation in aged mice via impaired induction of regulatory T cells.

bioRxiv : the preprint server for biology·2026
Same author

COMPARISON OF PEDIATRIC PATIENTS WITH PARS PLANITIS WHO UNDERWENT TREATMENT VERSUS OBSERVATION AT A TERTIARY REFERRAL EYE CENTER.

Retina (Philadelphia, Pa.)·2026
Same journal

Editorial: Imaging in the diagnosis and treatment of eye diseases.

Frontiers in ophthalmology·2026
Same journal

The traditional Chinese medicine bloodletting therapy at the Taiyang acupoint (No.EX-HN5) for the treatment of periorbital venous malformation: a case report.

Frontiers in ophthalmology·2026
Same journal

Confidence in managing open-globe injuries and endophthalmitis: a pre- and postwet-lab training evaluation.

Frontiers in ophthalmology·2026
Same journal

Health-related quality of life and tobacco and alcohol consumption in Leber hereditary optic neuropathy in Sweden.

Frontiers in ophthalmology·2026
Same journal

Primary posterior optic buttonholing as a new standard-of-care: rationale, technique, advantages, and special indications.

Frontiers in ophthalmology·2026
Same journal

Outcomes of allogeneic ocular surface stem cell transplantation.

Frontiers in ophthalmology·2026
See all related articles

ROSAH syndrome, a genetic disorder affecting vision, is caused by an ALPK1 gene mutation. While treatments can manage ocular inflammation and edema, they may not halt progressive retinal degeneration.

Area of Science:

  • Ophthalmology
  • Genetics
  • Rare Diseases

Background:

  • ROSAH syndrome is an autosomal dominant disorder linked to alpha kinase 1 (ALPK1) gene mutations.
  • This study examines three relatives with ROSAH syndrome, detailing their clinical presentation and treatment responses.

Observation:

  • A 16-year-old male and his family members exhibited symptoms including optic disc edema, macular edema, retinal degeneration, and uveitis.
  • Genetic analysis revealed a shared heterozygous ALPK1 gene mutation (c.710C>T) confirming ROSAH syndrome.

Findings:

  • Ophthalmic manifestations included optic nerve edema, panuveitis, glaucoma, and extensive cone and rod dysfunction.
  • The proband's macular edema responded to intravitreal dexamethasone and systemic tocilizumab.
  • Despite immunosuppressive therapy, progressive retinal degeneration was observed.
Keywords:
ALPK1ROSAHoptic disc edemaretinal degenerationuveitis

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.7K
Production and Detection of Reactive Oxygen Species ROS in Cancers
07:17

Production and Detection of Reactive Oxygen Species ROS in Cancers

Published on: November 21, 2011

69.9K

Related Experiment Videos

Last Updated: May 15, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

340
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.7K
Production and Detection of Reactive Oxygen Species ROS in Cancers
07:17

Production and Detection of Reactive Oxygen Species ROS in Cancers

Published on: November 21, 2011

69.9K

Implications:

  • Diagnosing ROSAH syndrome involves recognizing characteristic ocular signs and confirming with ALPK1 gene sequencing.
  • Current treatments may alleviate inflammation and edema but do not prevent vision loss due to retinal degeneration.